Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 141

    1.

    Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis.

    Brunet S, Labopin M, Esteve J, Cornelissen J, Socié G, Iori AP, Verdonck LF, Volin L, Gratwohl A, Sierra J, Mohty M, Rocha V.

    J Clin Oncol. 2012 Mar 1;30(7):735-41. Epub 2012 Jan 30.

    PMID:
    22291086
    [PubMed - in process]
    2.

    ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.

    Xu H, Cheng C, Devidas M, Pei D, Fan Y, Yang W, Neale G, Scheet P, Burchard EG, Torgerson DG, Eng C, Dean M, Antillon F, Winick NJ, Martin PL, Willman CL, Camitta BM, Reaman GH, Carroll WL, Loh M, Evans WE, Pui CH, Hunger SP, Relling MV, Yang JJ.

    J Clin Oncol. 2012 Mar 1;30(7):751-7. Epub 2012 Jan 30.

    PMID:
    22291082
    [PubMed - in process]
    3.

    Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia.

    Marcucci G, Metzeler KH, Schwind S, Becker H, Maharry K, Mrózek K, Radmacher MD, Kohlschmidt J, Nicolet D, Whitman SP, Wu YZ, Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Moore JO, Caligiuri MA, Larson RA, Bloomfield CD.

    J Clin Oncol. 2012 Mar 1;30(7):742-50. Epub 2012 Jan 30.

    PMID:
    22291079
    [PubMed - in process]
    4.

    Prediction of early death in acute myeloid leukemia.

    Ferrara F.

    J Clin Oncol. 2012 Feb 1;30(4):462-3; author reply 463-4. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184399
    [PubMed - indexed for MEDLINE]
    5.

    Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental?

    Gopaluni S, Sanyal S, Bair A, Vajpayee N.

    J Clin Oncol. 2012 Feb 10;30(5):e58-61. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184394
    [PubMed - indexed for MEDLINE]
    6.

    From mitochondrial biology to magic bullet: navitoclax disarms BCL-2 in chronic lymphocytic leukemia.

    Walensky LD.

    J Clin Oncol. 2012 Feb 10;30(5):554-7. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184389
    [PubMed - indexed for MEDLINE]
    7.

    Targeted therapy for chronic lymphocytic leukemia: a glimpse into the future.

    Hillmen P.

    J Clin Oncol. 2012 Feb 10;30(5):469-70. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184387
    [PubMed - indexed for MEDLINE]
    8.

    Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease.

    Roberts AW, Seymour JF, Brown JR, Wierda WG, Kipps TJ, Khaw SL, Carney DA, He SZ, Huang DC, Xiong H, Cui Y, Busman TA, McKeegan EM, Krivoshik AP, Enschede SH, Humerickhouse R.

    J Clin Oncol. 2012 Feb 10;30(5):488-96. Epub 2011 Dec 19.

    PMID:
    22184378
    [PubMed - indexed for MEDLINE]
    9.

    Not only response but early response to tyrosine kinase inhibitors in chronic myeloid leukemia.

    Cortes JE.

    J Clin Oncol. 2012 Jan 20;30(3):223-4. Epub 2011 Dec 19. No abstract available.

    PMID:
    22184376
    [PubMed - indexed for MEDLINE]
    10.

    Familial aggregation of acute myeloid leukemia and myelodysplastic syndromes.

    Goldin LR, Kristinsson SY, Liang XS, Derolf AR, Landgren O, Björkholm M.

    J Clin Oncol. 2012 Jan 10;30(2):179-83. Epub 2011 Dec 12.

    PMID:
    22162584
    [PubMed - indexed for MEDLINE]
    11.

    Diffuse osteosclerosis-associated acute myeloid leukemia.

    Ward DE, Fondaw MB, Shroff SK, Reddy VS, Khaled YA.

    J Clin Oncol. 2012 Jan 1;30(1):e3-4. Epub 2011 Nov 28. No abstract available.

    PMID:
    22124108
    [PubMed - indexed for MEDLINE]
    12.

    Use of arsenic trioxide as a first-line single agent in the treatment of acute promyelocytic leukemia.

    Keyhani M.

    J Clin Oncol. 2012 Jan 10;30(2):217; author reply 218-20; discussion 220-2. Epub 2011 Nov 28. No abstract available.

    PMID:
    22124099
    [PubMed - indexed for MEDLINE]
    13.

    Research on acute promyelocytic leukemia conducted in Iran.

    Mahmoudi N.

    J Clin Oncol. 2012 Jan 10;30(2):217-8; author reply 218-20; discussion 220-2. Epub 2011 Nov 28. No abstract available.

    PMID:
    22124097
    [PubMed - indexed for MEDLINE]
    14.

    Hairy cell leukemia variant, a new entity of the WHO 2008.

    Wang X, Spielberger R, Huang Q.

    J Clin Oncol. 2011 Dec 20;29(36):e864-6. Epub 2011 Nov 21. No abstract available.

    PMID:
    22105821
    [PubMed - indexed for MEDLINE]
    15.

    Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype.

    Yi JH, Huh J, Kim HJ, Kim SH, Kim HJ, Kim YK, Sohn SK, Moon JH, Kim SH, Kim KH, Won JH, Mun YC, Kim H, Park J, Jung CW, Kim DH.

    J Clin Oncol. 2011 Dec 10;29(35):4702-8. Epub 2011 Nov 14.

    PMID:
    22084373
    [PubMed - indexed for MEDLINE]
    16.

    Activity of alemtuzumab in acute myelogenous leukemia and myelodysplastic syndrome with chromosome 7 aberrations.

    Tibes R, Noel P.

    J Clin Oncol. 2011 Dec 20;29(36):4841-2; author reply 4842. Epub 2011 Nov 14. No abstract available.

    PMID:
    22084365
    [PubMed - indexed for MEDLINE]
    17.

    Assessment of BCR-ABL1 transcript levels at 3 months is the only requirement for predicting outcome for patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

    Marin D, Ibrahim AR, Lucas C, Gerrard G, Wang L, Szydlo RM, Clark RE, Apperley JF, Milojkovic D, Bua M, Pavlu J, Paliompeis C, Reid A, Rezvani K, Goldman JM, Foroni L.

    J Clin Oncol. 2012 Jan 20;30(3):232-8. Epub 2011 Nov 7.

    PMID:
    22067393
    [PubMed - indexed for MEDLINE]
    18.

    DNMT3A mutations in acute myeloid leukemia: impact on low-risk patients with CEBPA mutations.

    Masuda S.

    J Clin Oncol. 2011 Dec 1;29(34):4592-3; author reply 4593-4. Epub 2011 Oct 31. No abstract available.

    PMID:
    22042957
    [PubMed - indexed for MEDLINE]
    19.

    Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.

    Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K, Kumaran T, Ardeshna KM, Pagliuca A, Taylor GP, Fields PA.

    J Clin Oncol. 2011 Dec 10;29(35):4696-701. Epub 2011 Oct 31.

    PMID:
    22042945
    [PubMed - indexed for MEDLINE]
    20.

    Intracerebral infiltration as the unique cause of the clinical presentation of chronic lymphocytic leukemia/small lymphocytic leukemia.

    Tonino SH, Rijssenbeek AL, Oud ME, Pals ST, van Oers MH, Kater AP.

    J Clin Oncol. 2011 Dec 1;29(34):e837-9. Epub 2011 Oct 24. No abstract available.

    PMID:
    22025138
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk